NASDAQ
Liquidia shares have surged 43.9% since an October upgrade, as Zacks highlights stock wins and portfolio results despite a volatile market....
AWH Capital L.P. bought a new position in shares of Liquidia Corporation (NASDAQ: LQDA) in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange C...
The consensus price target hints at a 51.2% upside potential for Liquidia Corporation (LQDA). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earni...
Liquidia Corporation ( LQDA ) Jefferies London Healthcare Conference 2025 November 18, 2025 8:00 AM EST Company Participants Roger Jeffs - CEO & Director Michael Kaseta - COO & CFO Conference Call Par...
California-based TCG Crossover Management added 1.7 million shares of Liquidia for an estimated $38.9 million in the third quarter. The position represented 1.9% of reported assets at quarter-end....
The consensus price target hints at a 62.3% upside potential for Liquidia Corporation (LQDA). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earni...
Y Intercept Hong Kong Ltd acquired a new stake in shares of Liquidia Corporation (NASDAQ: LQDA) in the second quarter, according to the company in its most recent filing with the SEC. The firm acquire...
Liquidia Corporation has just posted strong Q3 results after a recent FDA approval, and the commercial launch of YUTREPIA is showing solid early sales traction. The Q3 earnings beat has triggered nume...
Liquidia Corporation ( LQDA ) Q3 2025 Earnings Call November 3, 2025 8:30 AM EST Company Participants Jason Adair - Chief Business Officer Roger Jeffs - CEO & Director Michael Kaseta - COO & CFO Scott...
MORRISVILLE, N.C., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA), a biopharmaceutical company revolutionizing care for patients with challenging respiratory and vascular diseas...
No price data available for this timeframe.